Clinical Trial Update: Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 feasibility study of the SOL regimen (S-1, leucovorin, and oxaliplatin) in patients with advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Jilin Provincial Tumor Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN